New Year’s resolution: Have more sex

January 8, 2010

By Elizabeth Cohen, CNN Senior Medical Correspondent

(CNN) — Yoga instructor Sadie Nardini and her husband got an early start on their New Year’s resolution: In December, the New York couple decided to have sex every day for the entire month.

Nardini and her husband, a professional photographer, initially decided to have sex like bunnies in the hopes that all the activity might help them overcome his-and-her bad habits: cigarettes and chocolate, respectively. And indeed, the nightly trysts did help. But they also found, unexpectedly, that frequent sex made them feel better in other ways, too.

Health benefits enjoyed by people who have frequent sex:

1. A longer life
2. A healthier heart
3. Lower blood pressure
4. Lower risk of breast cancer
5. Lower risk of prostate cancer
6. Pain relief
7. A slimmer physique
8. Better testosterone levels
9. Fewer menopause symptoms
10. Healthier semen

Read why…

Filed under: BODY, MIND, SPIRIT | Comments (0)

Among Men Living With Early, Untreated Prostate Cancer, Study Finds Acceptable Levels Of Anxiety

July 28, 2009

Men with early stages of prostate cancer who delay radical treatment in favor of an approach of “expectant management” do not have high levels of anxiety and distress. That is the conclusion of a new study published in the September 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society. The study’s results suggest that living with untreated cancer is not upsetting for many patients with early prostate cancer.

Filed under: BODY, MIND, News | Comments (0)

Green Tea Slows Down Prostate Cancer Progression Significantly

June 20, 2009

A study carried out by researchers in the Feist-Weiller Cancer Center, LSU Health Sciences Center-Shreveport, USA, found that men with prostate cancer who consumed the active compounds found in green tea had considerable reduction in serum markers predictive of prostate cancer progression. The study has been published in Cancer Prevention Research, an American Association for Cancer Research journal. James A. Cardelli, Ph.D.

Filed under: BODY | Comments Off

A Novel Communication Role For CYP17A1 In The Progression Of Castration-Resistant Prostate Cancer

June 15, 2009

UroToday.com – This publication describes our unique finding that the steroidogenic enzyme CYP17A1 is present in prostate derived exosomes, isolated from human serum.

Filed under: News | Comments Off

FOCUS On FOCIS: Combined Chemo-Immunotherapy For The Treatment Of Hormone-Refractory Metastatic Prostate Cancer

June 15, 2009

UroToday.com – The long-term goal of the Tumor Immunology and Immunotherapy group at The Institute of Immunology, Charles University, 2nd Medical School is the development of dendritic cell-based cancer vaccine.

Filed under: News | Comments Off

Aberrant ERG Expression Cooperates With Loss Of PTEN To Promote Cancer Progression In The Prostate

June 15, 2009

UroToday.com – Two papers in the May 5, 2009 edition of Nature Genetics link ERG chromosomal gene translocations with loss of PTEN in the early stages of prostate cancer (CaP) progression. Both are reviewed in Urotoday. In this report, Dr. Brett Carver and colleagues studied TMPRSS2-ERG genetic rearrangement, which are reported in up to 50% of primary prostate cancer tumors.

Filed under: News | Comments Off

Racial Differences In Risk Of Prostate Cancer Associated With Metabolic Syndrome

June 15, 2009

UroToday.com – The metabolic syndrome is estimated to occur in 25-35% of U.S. adults and is defined by having 3 of the following 5 features; abdominal obesity, hypertriglyceridemia, low high-density lipoprotein cholesterol, hypertension, and high fasting blood glucose. Studies suggest that the men with the metabolic syndrome are 50% more likely to be diagnosed with prostate cancer (CaP).

Filed under: News | Comments Off

Dose Measurement During Prostate Cancer Treatment

June 15, 2009

A new PTB measuring system offers the possibility of measuring the absorbed dose in the direct environment of the irradiated tumour During radiation therapy, the physicians try to keep the dose in the tumour as high as possible to destroy as many cancer cells as possible. To avoid the damaging of healthy tissue, it is becoming more and more important to check the exact amount of the dose.

Filed under: News | Comments Off

Impact Of Surgeon And Hospital Volume On Outcomes Of Radical Prostatectomy

June 15, 2009

UroToday.com – In the online edition of Urologic Oncology, Dr. Michael Cookson and his colleagues at Vanderbilt University reviewed the impact of surgeon and hospital volume on outcomes of radical prostatectomy (RP). They concluded that better outcomes are associated with higher volume surgeons and centers. The report is a literature review.

Filed under: News | Comments Off